These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37845841)

  • 1. Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE.
    Zhao W; Li Y; Sun H; Zhang W; Li J; Jiang T; Jiang L; Meng H
    J Cell Mol Med; 2023 Dec; 27(24):4045-4055. PubMed ID: 37845841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
    van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
    Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal and spatial changes in synaptic vesicle glycoprotein 2A (SV2A) under kainic acid induced epileptogenesis: An autoradiographic study.
    Pazarlar BA; Madsen CA; Oyar EÖ; Eğilmez CB; Mikkelsen JD
    Epilepsy Res; 2022 Jul; 183():106926. PubMed ID: 35526328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
    Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
    Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [
    Xiao L; Xiang S; Chen C; Zhu H; Zhou M; Tang Y; Feng L; Hu S
    Psychiatry Clin Neurosci; 2024 Aug; 78(8):456-467. PubMed ID: 38804583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain.
    Mikkelsen JD; Aripaka SS; Bascuñana P; Bankstahl M; Bankstahl JP; Pazarlar BA
    Neuroscience; 2022 Sep; 499():142-151. PubMed ID: 35878719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model.
    Contreras-García IJ; Pichardo-Macías LA; Santana-Gómez CE; Sánchez-Huerta K; Ramírez-Hernández R; Gómez-González B; Rocha L; Mendoza Torreblanca JG
    Epilepsy Behav; 2018 Nov; 88():283-294. PubMed ID: 30336420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of multidrug resistance gene and topiramate affect expression of multidrug resistance gene in the hippocampus of spontaneous epileptic rats].
    Jin RF; Sun RP; Xu XP
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):733-7. PubMed ID: 16255849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.
    Talos DM; Chang M; Kosaras B; Fitzgerald E; Murphy A; Folkerth RD; Jensen FE
    Pediatr Res; 2013 Jan; 73(1):24-30. PubMed ID: 23138400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.
    Lynch JM; Tate SK; Kinirons P; Weale ME; Cavalleri GL; Depondt C; Murphy K; O'Rourke D; Doherty CP; Shianna KV; Wood NW; Sander JW; Delanty N; Goldstein DB; Sisodiya SM
    Epilepsy Res; 2009 Jan; 83(1):44-51. PubMed ID: 18977120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats.
    Shi J; Zhou F; Wang LK; Wu GF
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):716-722. PubMed ID: 26489628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.
    Romoli M; Mandarano M; Romozzi M; Eusebi P; Bedetti C; Nardi Cesarini E; Verzina A; Calvello C; Loreti E; Sidoni A; Giovenali P; Calabresi P; Costa C
    J Neurol; 2019 Sep; 266(9):2273-2276. PubMed ID: 31168673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of levetiracetam on hippocampal CA1 synaptic plasticity and molecular changes in the dentate gyrus in epileptic rats.
    Salaka RJ; Nair KP; Sasibhushana RB; Udayakumar D; Kutty BM; Srikumar BN; Shankaranarayana Rao BS
    Neurochem Int; 2022 Sep; 158():105378. PubMed ID: 35753511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the anticonvulsant effect of dapsone on metabolic activity assessed by [
    Ríos C; Aguirre-Aranda I; Avendaño-Estrada A; Ángel Ávila-Rodríguez M; Manjarrez-Marmolejo J; Franco-Pérez J; Islas-Cortez M; Ruiz-Diaz A; Méndez-Armenta M; Diaz-Ruiz A
    Brain Res; 2023 Mar; 1803():148227. PubMed ID: 36592802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.
    Contreras-García IJ; Gómez-Lira G; Phillips-Farfán BV; Pichardo-Macías LA; García-Cruz ME; Chávez-Pacheco JL; Mendoza-Torreblanca JG
    Brain Sci; 2021 Apr; 11(5):. PubMed ID: 33922424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat.
    Chuang YC; Chang AY; Lin JW; Hsu SP; Chan SH
    Epilepsia; 2004 Oct; 45(10):1202-9. PubMed ID: 15461674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus.
    Wu Q; Wang H
    Epilepsy Res; 2018 Dec; 148():8-16. PubMed ID: 30317115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with intravenous levetiracetam in the rhesus monkey Coriaria lactone-induced status epilepticus model.
    Cheng L; Lei S; Chen SH; Hong Z; Yang TH; Li L; Chen F; Li HX; Zhou D; Li JM
    J Neurol Sci; 2015 Jan; 348(1-2):111-20. PubMed ID: 25579413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
    Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
    Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
    Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
    Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.